CAYLA MAYS: Open Payments
NPI 1255099503 · MUNCIE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,989 in 118 payments from 14 companies in 2025. Trend: 2023 $2,175 · 2024 $1,753 · 2025 $1,989
Food & beverage: $1,874Education: $115
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 33 | $474 |
| Janssen Biotech, Inc. | 10 | $300 |
| Novartis Pharmaceuticals Corporation | 18 | $242 |
| Amgen Inc. | 16 | $235 |
| UCB, Inc. | 12 | $192 |
| Lilly USA, LLC | 8 | $122 |
| GlaxoSmithKline, LLC. | 6 | $105 |
| Mallinckrodt Hospital Products Inc. | 5 | $97 |
| PFIZER INC. | 3 | $57 |
| Organon LLC | 2 | $54 |
Products named: RINVOQ, TREMFYA, Bimzelx, COSENTYX, SKYRIZI, TALTZ, OTEZLA, BENLYSTA.
Industry payments across IN — which companies pay providers there.
